C3G

Clinical trials for C3G explained in plain language.

Never miss a new study

Get alerted when new C3G trials appear

Sign up with your email to follow new studies for C3G, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 2 Terminated 1

New drug OMS721 tested for rare kidney conditions

Disease control Terminated

This study tested a drug called OMS721 in 31 people with certain kidney diseases, including IgA nephropathy and lupus nephritis. The main goal was to check if the drug is safe and if it reduces protein in the urine, a sign of kidney damage. The study was stopped early, so results…

Matched conditions: C3G

Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

C3G

Get alerted when new C3G trials appear

New drug OMS721 tested for rare kidney conditions